Malaysia Medical Device Registration Cost 2026: MAR Pricing Models, Flat Fee vs Hourly Billing, and 3-Year Cash Flow Comparison

How Much Does It Cost to Register a Medical Device in Malaysia in 2026?

For a single foreign-manufactured device entering Malaysia in 2026, expect a 3-year all-in budget of roughly USD 8,000–22,000 for a Class A/B device and USD 14,000–55,000 for a Class C/D device, excluding MDA government fees, CAB review fees, and clinical evidence preparation. Malaysia has a three-fee architecture: the Conformity Assessment Body (CAB) charges its own technical-review fee, the Medical Device Authority charges its own registration fee, and your Malaysia Authorized Representative (MAR) charges a service fee on top of both. Most cost variance comes from the third one — how your MAR bills you.

Three pricing models dominate the MAR market today, and the difference between the cheapest and most expensive can exceed 4x over three years for the same scope of work:

MAR Pricing Model	Year 1 Cost (Class B, 1 device)	Year 1 Cost (Class C, 1 device)	3-Year Total (Class B)	3-Year Total (Class C)
Hourly billing	$7,000–$13,000	$18,000–$36,000	$14,000–$24,000	$32,000–$58,000
Registration fee + lower annual	$5,000–$10,000	$11,000–$20,000	$9,000–$18,000	$19,000–$36,000
Flat all-inclusive annual fee	$2,000–$3,000	$3,000–$4,500	$6,000–$9,000	$9,000–$13,500

Government fees (MDA application MYR 250–750, MDA registration MYR 750–3,000) and CAB review fees are the same regardless of which MAR you pick. Your MAR bill is where you actually have leverage. This guide is about how to use it.

This article is the buyer-side procurement counterpart to MedDeviceGuide's Malaysia MDA Medical Device Registration Guide, which covers classification, pathways, MeDC@St mechanics, and the Singapore reliance route. Read that first if you have not yet decided pathway. This article focuses on what your MAR should cost you and how to write a contract that holds.

Skip to Your Scenario

• Single Class A or Class B device, pre-revenue startup: Read Scenario A first — flat fee saves $7,000–$10,000 in Year 1 cash.
• Single Class C or Class D device entering Malaysia: Read Scenario B — Year 1 burden under hourly is 70%+ of 3-year cost.
• Multi-device portfolio (3+ devices): Read Scenario C — tier discounts compound dramatically.
• Already have a MAR and want to switch: Skip to the MAR Switching Playbook.
• Issuing an RFP this week: Skip to the RFP Template and 8 questions to ask.
• Want to validate the numbers: Read the Named Provider RFP Comparison.
• Confused by the three-fee structure (CAB + MDA + MAR): Skip to Why MAR Pricing Is Where Malaysia Budgets Win or Lose.

Why MAR Pricing Is Where Malaysia Budgets Win or Lose

Malaysia's regulatory architecture under the Medical Device Act 2012 (Act 737) and Medical Device Regulations 2012 imposes three independent commercial relationships on every foreign manufacturer:

1. The MDA (Medical Device Authority, under Ministry of Health), which charges statutory application and registration fees and issues the registration certificate.
2. A Conformity Assessment Body (CAB), a private firm designated by MDA to perform technical review of Class B/C/D dossiers and issue a Conformity Assessment certificate. The CAB charges its own fee, separate from MDA's.
3. A Malaysia Authorized Representative (MAR), a Malaysian legal entity holding an MDA Establishment Licence and a valid GDPMD certificate, which holds the registration on the manufacturer's behalf, files via MeDC@St, manages importation authorizations, modifications, renewals, and serves as MDA's regulatory point of contact.

The MAR is not optional and not a one-time cost. Registrations are valid for 5 years per cycle and effectively indefinitely thereafter. Unlike a CAB engagement that ends when the certificate is issued, the MAR is a recurring vendor relationship — small differences in pricing model compound enormously over the device life.

Of the three relationships, the MAR is the only one where the buyer has real negotiating leverage. MDA fees are statutory (published in the Medical Device (Fees) Regulations, updated via Amendment Regulations like P.U.(A) 330/2025). CAB fees are quasi-market — there are several MDA-designated CABs but pricing converges around technical-review effort. MAR fees are pure private-sector pricing: multiple firms can perform the same statutory role, scope is well-defined (registration filings, Letters of Authorization, modifications, renewals, MeDC@St account management, vigilance, CAB liaison), and holder transfers are recognized procedurally by MDA.

The catch: most MAR pricing is not published. You issue an RFP, sign an NDA, and compare proposals with different scope inclusion lists and different treatment of modifications, importation letters, and renewals. That is the comparison this article is designed to short-circuit.

The Three MAR Pricing Models, Decoded

Model 1: Hourly billing ("charge by hour")

The default model for small-to-mid regulatory firms in Kuala Lumpur and the historical industry standard for Singapore-based regional consultancies. Scope is captured in a SoW; everything outside scope is billed at hourly rates of $115–$350/hour depending on tier:

Consultant Tier	Asia-Pacific Hourly Rate (2026)	Typical Work
Tier 1 — senior regulatory strategist	$290–$350/hr	MDA strategy, CAB selection disputes, vigilance escalations, audit defense
Tier 2 — regulatory specialist	$215–$265/hr	CSDT dossier preparation, Essential Principles checklists, MDA additional-information responses
Tier 3 — associate / documentation	$115–$155/hr	Translations, Letters of Authorization, file maintenance, MeDC@St data entry

(Source: MedDeviceGuide Medical Device Regulatory Consulting Hourly Rates by Region. Rates use the Asia-Pacific bracket, anchored on Singapore and applied to Kuala Lumpur.)

Why buyers choose hourly: flexibility, perceived control, ability to use the MAR only when needed.

Why hourly is bad for buyers in practice:

• No incentive to be efficient. Every hour the MAR spends is revenue.
• Surprise invoices. "Quick check with MDA" becomes 4 hours; CAB liaison call becomes 6 hours; the bill arrives 60 days after the work.
• Scope creep is invisible until it bills. A modification can be 2 hours or 20 — you find out after.
• Disincentive to communicate. Every email is potentially billable, so you ask fewer questions and get worse outcomes.
• Year 1 cash flow shock. First-year work (CSDT preparation, CAB submission, MeDC@St setup, initial LoAs) is front-loaded and frequently 3–5x the steady-state annual hours.

A typical Class C hourly engagement runs $18,000–$36,000 in Year 1 and $3,500–$9,000/year thereafter, with variance driven by MDA queries during the 30–60 working-day review window.

Model 2: Registration fee + lower annual maintenance

The dominant model for mid-to-large MAR service firms, including Singapore-based regional consultancies with Malaysian offices. Buyer pays a one-time setup/registration fee plus a smaller recurring annual fee. Scope is bundled but each "extra" is an itemized add-on.

Typical structure:

Component	Class A/B	Class C/D
One-time setup fee	$1,500–$3,000	$2,500–$5,000
Initial registration filing	$2,500–$5,000	$5,000–$12,000
Annual maintenance fee	$1,800–$3,500	$3,500–$7,000
Per-modification fee	$500–$2,500	$1,500–$5,500
Per-Letter-of-Authorization fee	$50–$400	$50–$400
CAB liaison and dossier handling	$1,500–$4,000 add-on	$2,500–$6,000 add-on
Renewal filing (every 5 years)	$1,500–$3,500	$3,000–$6,000

The trap: the marketing message is "low annual fee," but Year 1 actual spend is usually $5,000–$15,000 because every registration triggers setup + filing + CAB liaison + initial Letters of Authorization simultaneously.

Where this model fails buyers:

• Year 1 cash flow shock is structural. All major one-time fees fire in the same calendar year you have not yet started selling.
• Modifications are unbounded. Malaysia's active regulatory environment generates 1–3 modification filings per device per year for active products. At $2,000–$5,500 each, that is a $2,000–$10,000/year invisible tax.
• Letters of Authorization scale with imports. A high-volume distributor that ships monthly pays $2,400–$4,800/year just in administrative letters.
• Renewal cliff. At Year 5, registration renewal triggers another $1,500–$6,000 fee window most buyers forget to budget. Malaysia renews on a 5-year cycle — twice as often as Brazil's Class III/IV 10-year cycle — so the renewal cost compounds faster.

Model 3: Flat all-inclusive annual fee

A newer pricing model where the MAR charges a single annual fee covering the initial filing, all modifications, all Letters of Authorization, required translations, the renewal filing, and CAB coordination (the CAB's own fee remains separate pass-through). Same number every year.

Two structural advantages:

1. The fee curve is flat instead of front-loaded. Year 1 cost equals Year 3 cost. The pre-revenue period is no longer cash-flow-hostile.
2. MAR incentives align with yours. Once you sign, every additional hour the MAR spends is pure cost to them — they are motivated to file cleanly, avoid CAB rejections, and resolve MDA queries on the first response.

The catch: flat-fee MARs typically require a multi-year contract and exclude government fees, the CAB technical-review fee, certified translations for non-MDA authorities, and direct importation handling.

This model is also rare. As of April 2026, Pure Global is the only major MAR service provider that publishes a complete flat-fee schedule on its website (pureglobal.com/services/pricing), which makes it the only published reference point for buyers comparing models.

Why this guide uses Pure Global as the worked example

We use Pure Global's published MAR rates because they are the only flat-fee MAR rates in the public domain — anyone can verify them at pureglobal.com/services/pricing. This is not an endorsement. The published rates let us do an apples-to-apples cash flow comparison that would otherwise require RFPs to multiple firms operating under NDA. Industry ranges for hourly and front-loaded models come from typical RFP responses, Asia-Pacific consulting rate benchmarks, and MedDeviceGuide procurement data.

Recommended Reading

Thailand Medical Device Registration Cost 2026: Thai License Holder Pricing Models, Flat Fee vs Hourly Billing, and 3-Year Cash Flow Comparison

Regulatory Reimbursement & Market Access2026-04-24 · 41 min read

Pure Global Malaysia MAR Pricing (Published, April 2026)

Class A and Class B — Lower-Risk Devices

Number of Registrations	Annual Flat Fee (USD)	Approximate MYR (at MYR 4.7/USD)
1	$2,000	MYR 9,400
2	$3,000	MYR 14,100
3	$4,000	MYR 18,800
4	$5,000	MYR 23,500
5	$6,000	MYR 28,200
6	$6,500	MYR 30,550
7	$7,000	MYR 32,900
8	$7,500	MYR 35,250
9	$8,000	MYR 37,600
10	$8,500	MYR 39,950
11+	Custom quote	—

Included in the annual fee — per Pure Global's published price list ("preparation and submission of the registration, required translation, importation authorization, modifications, renewals, coordination with CAB, correspondence with authorities"):

• Preparation and submission of the MDA registration (filed via MeDC@St)
• Required translation (English / Bahasa Malaysia for the MDA submission)
• Importation authorization (the Letter-of-Authorization mechanism MDA recognises for licensed importers)
• Modifications to the registration after grant
• Renewals at the 5-year cycle
• Coordination with the CAB for technical review (the CAB's own review fee is a separate pass-through paid directly to the CAB — see "Not included" below)
• Correspondence with the authorities (routine MDA exchanges on the registered devices)

Inherent to the MAR statutory role under the Medical Device Act 2012 (Act 737) and Medical Device Regulations 2012 (included by definition, not separately billable):

• Holding the registration and acting as MDA's regulatory point of contact for the registered devices (Act 737 s. 16, MDR 2012)
• Forwarding vigilance reports (incident reports, FSCAs) between manufacturer and MDA under the Medical Device (Duties and Obligations of Establishments) Regulations 2019 — the MAR routes notifications; preparing the manufacturer's own incident analysis or root-cause investigation is not in scope
• Maintaining the MAR's own valid MDA Establishment Licence and GDPMD certificate (a regulatory requirement on the MAR firm itself; this is not Pure Global providing GDPMD services to the manufacturer's own QMS)

Confirm scope before signing — these activities are not itemised on Pure Global's published price list, so verify in writing whether they sit inside the annual fee or are quoted separately:

• "Unlimited" volume of Letters of Authorization for high-frequency importers (xlsx says "importation authorization" without quantifying volume)
• Per-shipment importation paperwork beyond the standard MDA-recognised LoA (e.g. ePermit/DagangNet voluntary submissions during the 2026–2027 transition)
• MDA additional-information request responses during the 90-day reply window — likely inside "correspondence with authorities" but not separately itemised
• Aesthetic-device transition filings under the June 2026 Designated Aesthetic Devices Order — likely inside "modifications" but worth confirming for HIFU / medical laser / liposuction portfolios
• FSCA preparation (as opposed to forwarding) and post-market surveillance report compilation

Not included — separately quoted, paid to a third party, or excluded entirely: MDA application and registration fees (statutory, passed through at cost), the CAB's own technical-review fee (paid directly to the CAB), GDPMD certification of the manufacturer's own QMS, certified translations required for non-MDA authorities, customs brokerage and physical importation handling, clinical evidence preparation, ePermit/DagangNet permit fees once mandatory enforcement begins July 2027. Pure Global's xlsx note on the CAB review fee says: "Pure Global can support with identifying and contacting CABs" — that support is inside the annual fee; the CAB's invoice is not.

Class C and Class D — Higher-Risk Devices

Number of Registrations	Annual Flat Fee (USD)	Approximate MYR (at MYR 4.7/USD)
1	$3,000	MYR 14,100
2	$4,500	MYR 21,150
3	$6,000	MYR 28,200
4	$7,500	MYR 35,250
5	$9,000	MYR 42,300
6	$10,000	MYR 47,000
7	$11,000	MYR 51,700
8	$12,000	MYR 56,400
9	$13,000	MYR 61,100
10	$14,000	MYR 65,800
11+	Custom quote	—

Included in the annual fee — same xlsx scope as Class A/B (preparation and submission, required translation, importation authorization, modifications, renewals, coordination with CAB, correspondence with authorities):

The xlsx Comments column applies the same inclusion list to Class C/D as to Class A/B — only the price tier changes. CAB coordination for higher-complexity technical review is therefore inside the fee under "coordination with CAB", and post-grant modifications are inside under "modifications".

Inherent to the MAR statutory role under Act 737 (in addition to the Class A/B statutory items above):

• Forwarding higher-volume vigilance and FSCA notifications between manufacturer and MDA for higher-risk devices (statutory routing duty, not preparation)

Confirm scope before signing — for Class C/D in particular, these activities have meaningful cost implications and are not itemised on Pure Global's published price list:

• MDA additional-information (AIR) responses during the 90-day reply window — likely inside "correspondence with authorities" for routine queries, but substantive technical re-argument of CAB or MDA findings can extend beyond that. Confirm in writing for borderline-classified Class C devices.
• Liaison on MDSAP-based or ISO 13485 QMS evidence during CAB review — confirm whether dossier-level QMS Q&A is inside "coordination with CAB" or quoted separately.
• FSCA preparation (drafting customer notification letters, root-cause investigation) as distinct from forwarding the FSCA notification.
• Clinical evidence Q&A during CAB review (CER updates, post-market clinical follow-up reporting) — clinical evidence preparation is explicitly excluded; the question is what counts as preparation versus dossier liaison.

Not included — separately quoted, paid to a third party, or excluded entirely: the CAB's own technical-review fee (typical range MYR 15,000–50,000+ for Class C/D, paid directly to the CAB), clinical evidence preparation, ePermit/DagangNet handling once enforced, GDPMD certification of the manufacturer's own QMS.

Contract Terms

• Standard contract: 3 years.
• Annual contract option: available, but the first-year fee is increased by 50%.
• Early termination: allowed at any time with a 50% payoff of the remaining contract value.
• Ad-hoc consulting (non-clients or out-of-scope work): typical Asia-Pacific rate card applies (T1/T2/T3 hourly tiers above).

(Source: pureglobal.com/services/pricing, captured April 2026. Price list version 1.1, last updated 2026-01-08.)

3-Year Cash Flow: Side-by-Side Comparison

The pricing model only matters because of cash timing. The following scenarios show the same scope of work — one device, MAR only, MDA government and CAB fees excluded — under each of the three models. Numbers are illustrative and based on the ranges given above.

Scope assumption. The Pure Global flat-fee column in these scenarios assumes that high-volume Letters of Authorization, MDA additional-information responses, and routine modifications associated with the registered devices sit inside the annual fee — consistent with the xlsx-listed scope ("importation authorization, modifications, correspondence with authorities") but not separately itemised by volume. Pure Global's published Comments column lists scope categories, not unit caps. Always confirm volume assumptions in writing before signing. The CAB's own technical-review fee is always a separate pass-through paid directly to the CAB regardless of which MAR you choose.

Scenario A: Single Class B Device, 3-Year Total

Cost Bucket	Hourly Billing	Registration + Annual	Flat Fee (Pure Global)
Year 1 setup + CSDT + CAB liaison	$8,500 (45 hrs × $190 blended)	$5,500 ($2,000 setup + $3,500 filing)	$2,000
Year 1 LoAs + initial modifications	$1,500 (10 hrs T3)	$1,200 (3 LoAs + 1 mod)	included
Year 1 total	$10,000	$6,700	$2,000
Year 2 maintenance + 1–2 mods	$3,500 (20 hrs blended)	$2,500 annual + $1,000 mods	$2,000
Year 3 maintenance + 1–2 mods	$3,500 (20 hrs blended)	$2,500 annual + $1,000 mods	$2,000
3-Year Total	$17,000	$13,700	$6,000
Year 1 share of 3-year spend	59%	49%	33%

The Year 1 burden under flat fee is $2,000 vs $10,000 under hourly — for the same regulatory output. That $8,000 of cash that does not leave the company in Year 1 is, for an early-stage MedTech, often the difference between launching in Malaysia this fiscal year and deferring 12 months until Singapore reliance certification clears.

Scenario B: Single Class C Device, 3-Year Total

Cost Bucket	Hourly Billing	Registration + Annual	Flat Fee (Pure Global)
Year 1 CSDT, CAB submission, MDA filing	$24,000 (120 hrs × $200 blended)	$13,000 ($3,500 setup + $9,500 filing)	$3,000
Year 1 CAB liaison + MDA AIR responses	$4,000	$2,500	included
Year 1 LoAs + initial modifications	$2,000	$1,500	included
Year 1 total	$30,000	$17,000	$3,000
Year 2 maintenance + 2 mods + LoAs	$6,500 (35 hrs)	$5,000 annual + $2,000 mods	$3,000
Year 3 maintenance + 2 mods + LoAs	$6,500 (35 hrs)	$5,000 annual + $2,000 mods	$3,000
3-Year Total	$43,000	$31,000	$9,000
Year 1 share of 3-year spend	70%	55%	33%

Under hourly, 70% of the 3-year MAR cost lands in Year 1 — the worst possible time for a Malaysia entrant who has not yet earned ringgit revenue. Flat fee distributes the same scope of work evenly, freeing roughly $27,000 of Year 1 working capital for CAB technical-review fees, GDPMD support for the MAR's own audit cycle, distributor onboarding, or sales hires.

Scenario C: 5-Device Portfolio (3 Class B + 2 Class C)

Cost Bucket	Hourly Billing	Registration + Annual	Flat Fee (Pure Global)
Year 1 total	$55,000–$85,000	$32,000–$50,000	$4,000 (3 Class B) + $4,500 (2 Class C) = $8,500
Year 2	$16,000–$28,000	$13,000–$22,000	$8,500
Year 3	$16,000–$28,000	$13,000–$22,000	$8,500
3-Year Total	$87,000–$141,000	$58,000–$94,000	$25,500

For multi-device portfolios, the flat-fee tier discount compounds. A 5-device portfolio at Pure Global's published rates costs less than a single Class C device under hourly billing.

What "All-Inclusive" Actually Means: Scope Checklist

When MAR proposals all claim to "include everything," the differences are in the fine print. Compare line by line.

Service Item	Hourly (typical)	Reg + Annual (typical)	Flat Fee — Pure Global
Initial registration filing via MeDC@St	hourly	one-time setup fee	included (published)
English / Bahasa Malaysia translation of submission docs	hourly	sometimes included, sometimes per-page	included (published)
Letters of Authorization for importation (per shipment)	hourly per letter	$50–$400 each	included (published) — volume cap confirm with provider
Modifications (labeling, specs, manufacturer change)	hourly per modification	$500–$5,500 each	included (published)
MDA additional-information request (AIR) responses	hourly	hourly above contract scope	confirm with provider (likely inside "correspondence with authorities")
CAB technical-review liaison and dossier resubmission	hourly	$1,500–$6,000 add-on	included (published)
5-year registration renewal filing	hourly	$1,500–$6,000 extra	included (published)
Distributor authorization letters	$100–$400 each	$100–$400 each	confirm with provider (likely inside "importation authorization")
Vigilance / adverse-event report forwarding (statutory)	hourly	hourly or per-event	inherent to statutory role under Act 737
FSCA notification forwarding (routing)	hourly	hourly	inherent to statutory role under Act 737
FSCA preparation (customer letters, root-cause analysis)	hourly	hourly	confirm with provider — preparation vs. forwarding distinction
Aesthetic-device transition filings (P.U.(A) 2026 order)	hourly	hourly	confirm with provider (likely inside "modifications")
ePermit/DagangNet voluntary submissions	hourly	hourly	confirm with provider
MDA / CAB fees (statutory and third-party)	passed through	passed through	passed through at cost (no markup)
GDPMD support for the manufacturer's own audits	hourly	hourly	separate (consulting menu)
Clinical evidence preparation (Class C/D)	hourly	hourly	separate (consulting menu)
Certified translations for non-MDA authorities	hourly	extra	separate (consulting menu)
Customs brokerage and importation handling	not in MAR scope	not in MAR scope	not included (third-party broker)

The scope items that quietly drive Year-2+ cost overruns under hourly and reg-plus-annual are: modifications, Letters of Authorization, MDA query responses, and the 5-year renewal — together generally 40–70% of post-Year-1 MAR spend. Whether they are inside or outside the flat fee is the single biggest line in any side-by-side comparison.

Recommended Reading

Brazil Medical Device Registration Cost 2026: BRH Pricing Models, Flat Fee vs Hourly Billing, and 3-Year Cash Flow Comparison

ANVISA Reimbursement & Market Access2026-04-24 · 34 min read

What 2026 Malaysia Regulatory Churn Costs Under Each Pricing Model

Malaysia's regulatory environment 2022–2026 has been more active than any period since Act 737 took effect. Each rule change forces modifications, fresh CSDT updates, repackaged labeling, or reclassification under updated AMDD-aligned rules. Under hourly or reg-plus-annual, every filing is billable. Under flat fee, none are. This is where the case for flat fee gets quantitatively compelling.

Modification Volume from 2022–2026 MDA Rules

The table below shows the cumulative modification load a typical device on the Malaysian market has absorbed in the four years since the post-COVID Act 737 implementation tightening began.

Regulation / Programme	Effective	Typical Modifications per Device
MDA online classification mandate	May 2025	1 filing
P.U.(A) 330/2025 (Amendment Regulations 2025)	January 2026	1 filing (Class A)
MDA/GD/0070 Second Edition	October 2025	1 filing (verification-pathway devices)
MDSAP recognition	September 2025	1 filing
MDA–HSA Singapore reliance pilot → permanent	March 2026	1–2 filings (eligible devices)
MDA–Thai FDA reliance pilot	2025–2026	1 filing (Thai-cascade devices)
Designated Aesthetic Devices Order 2026	June 2026	1–2 filings (affected devices)
ePermit/DagangNet voluntary window	June 2026	1 voluntary filing
Periodic labeling / IFU clarifications	Ongoing	1–2 per device per year
Act 737 amendment package (proposed reform)	Phased 2026–2027	1–3 filings per device

Aggregated, a typical Class B device sold in Malaysia has filed 4–8 cumulative modifications since 2022. Class C/D devices, with broader CSDT scope and higher post-market obligations, are closer to 7–13 filings.

What That Modification Volume Costs You

Pricing Model	Per-Filing Cost	4-Year Cost (Class B, 6 filings)	4-Year Cost (Class C, 12 filings)
Hourly billing (3–8 hrs × $215 blended)	$645–$1,720	$3,870–$10,320	$7,740–$20,640
Reg fee + annual ($500–$5,500 each)	$500–$5,500	$3,000–$33,000	$6,000–$66,000
Pure Global flat fee	included	$0 incremental	$0 incremental

Under hourly or reg-plus-annual, regulatory churn becomes a hidden tax that scales with how active the regulator is — not with how active you are. MDA is currently one of the more active medical device regulators in ASEAN, accelerated by the 2025–2026 reform package. That is exactly the wrong environment in which to sign a 3-year hourly contract.

What MDA Has Queued for 2026–2028

The pipeline already in consultation, pilot, or scheduled, each of which will trigger fresh filings:

• Act 737 amendment package (proposed 2025–2026): expanded vigilance and post-market surveillance obligations, UDI roadmap formalization, distributor due-diligence tightening.
• UDI implementation roadmap 2024–2026: voluntary phase opening, expected mandatory phase 2027–2028 mirroring ASEAN AMDD harmonization — at minimum one labeling modification per device per phase.
• ePermit/DagangNet mandatory enforcement (July 2027): every active registration needs an import-permit linkage. Voluntary window opens June 2026.
• MeCAS portal modernization: MDA has signaled migration of MeDC@St functionality into a modernized centralised system; transition periods historically generate one administrative re-submission per registration.
• CAB recognition expansion 2024–2025: new CABs designated and existing CAB scopes widened, occasionally requiring cascading CSDT updates.
• Halal medical device requirements for selected categories: voluntary today, expected to formalize during the Act 737 reform window.
• IVD reclassification per ASEAN AMDD framework: ongoing reclassification under the AMDD risk framework, materially shifting dossier requirements.
• Aesthetic devices transition: the June 2026 designation will trigger fresh registrations across HIFU, medical laser, and liposuction equipment categories.

A reasonable 2026–2028 forecast for an existing Class C device on the market is 3–5 additional modifications. At hourly rates that is another $2,000–$10,000 per device. Under flat fee, $0.

For a portfolio holder with 5 Class C devices, the difference between "modifications included" and "modifications billable" over 2026–2028 is roughly $10,000–$50,000 in net Malaysia P&L impact — money that ends up either in your operating budget or in your MAR's invoice. Same regulatory work, same outcome with MDA, just different invoice line.

When Flat Fee Wins, and When It Does Not

Flat fee is not universally the best choice. The decision framework:

Flat fee usually wins when:

• You expect to keep the device on the Malaysian market for ≥3 years (especially through one full 5-year renewal cycle).
• You have ≥2 devices in your portfolio (tier discounts compound).
• Devices are commercially active — ongoing LoAs, modifications, distributor changes, labeling updates.
• You are pre-revenue or capital-constrained in Year 1 and want to smooth cash outflow.
• You are entering via the Singapore reliance route — the one-time conversion filing per device should not be billed at hourly rates.
• You plan to expand the portfolio over the contract life.

Hourly billing might still win when:

• One-time discovery exercise (regulatory feasibility, classification opinion, ASEAN scoping) with no registration to maintain.
• Single Class A device filed once and never modified, not overlapping aesthetic-device or measuring-device sub-categories.
• Ad-hoc strategic counsel (e.g., MDA enforcement response) outside an existing MAR relationship.

Registration-fee-plus-annual is rarely the optimal choice on TCO grounds. It typically lands between hourly and flat fee on cost while preserving Year 1 front-loading and exposing you to per-modification and per-LoA fees that ratchet up with regulatory churn.

Government Fees: A Quick Reference

MAR service fees are excluded from MDA government fees and CAB review fees in every model. For completeness, the official 2026 government fees (in the three-fee architecture) are:

Filing	Government Fee (MYR)	Approximate USD
MDA application — Class A	MYR 500	~$106
MDA application — Class B	MYR 250	~$53
MDA application — Class C	MYR 500	~$106
MDA application — Class D	MYR 750	~$160
MDA registration — Class A	MYR 750	~$160
MDA registration — Class B	MYR 1,000	~$213
MDA registration — Class C	MYR 2,000	~$426
MDA registration — Class D	MYR 3,000	~$638
CAB technical-review fee — Class B	typically MYR 8,000–25,000	~$1,700–$5,300
CAB technical-review fee — Class C/D	typically MYR 15,000–50,000+	~$3,200–$10,600+

(MDA does not publish CAB technical-review fees; the ranges above are industry estimates from buyer-side RFPs and CAB price lists in 2025–2026. Pure Global's MAR scope explicitly includes CAB coordination and assistance with identifying and engaging a designated CAB, but the CAB's own technical-review fee is a pass-through cost paid directly to the CAB.)

For a complete walkthrough of Malaysia's classification rules, registration pathways, MeDC@St mechanics, GDPMD requirements, the Singapore reliance route, and Act 737 amendment roadmap, see the Malaysia MDA Medical Device Registration Guide.

Recommended Reading

UK Medical Device Registration Cost 2026: UKRP Pricing Models, Flat Fee vs Hourly Billing, and 3-Year Cash Flow Comparison

Reimbursement & Market Access Commercialization2026-04-24 · 41 min read

8 Questions to Ask Any MAR Before You Sign

Demand explicit, written answers before signing — not verbal assurances during the sales call.

1. Is the fee fixed for the contract term, or subject to annual escalation? If escalation: capped at what (CPI? Bank Negara CPI? uncapped?).
2. How many Letters of Authorization are included per year? "Unlimited" should be in writing. "Reasonable use" is a red flag.
3. How many modifications are included per year? Is the cap per device or per portfolio? What counts as a modification (labeling? IFU? manufacturer change? aesthetic-device transition filing under the June 2026 order?).
4. What is the per-hour rate for out-of-scope work? Some firms charge $400+/hour for anything outside scope, including routine MDA queries.
5. Who pays for MDA additional-information responses during the 90-day reply window? Under hourly, you do. Under flat fee, the MAR should. Confirm in writing.
6. What are the termination terms? Pure Global publishes 50% payoff of remaining contract value. Many competitors require 100% payoff or 12-month notice. This matters more than headline price.
7. Does the MAR hold the registration or does the distributor? If a distributor doubles as your MAR, switching distributors typically requires a transfer or re-registration. Insist on a registration held by an independent MAR.
8. Will the MAR provide a transfer letter at no cost if you leave? Confirm release of MeDC@St credentials, the CAB certificate, and the registration certificate within a defined number of days.

If a MAR refuses to answer any of these in writing, that is the answer to the question.

MAR Switching Playbook: How to Leave Without Getting Trapped

The most expensive mistake in MAR selection is signing a contract you cannot exit affordably. Many foreign manufacturers discover, 18 months in, that their MAR is mediocre but switching costs more than staying. This is the operational playbook competitors avoid publishing.

The MDA Holder Change Procedure

MDA permits transfer of the registration holder under the Medical Device Regulations 2012. The mechanic:

Step	Who Performs	Typical Duration	Notes
1. Manufacturer issues new Letter of Authorization to incoming MAR	Manufacturer + new MAR	1–2 weeks	Notarised; some MAR contracts require apostille
2. Outgoing MAR releases transfer letter and MeDC@St handover	Outgoing MAR	0 days to 6 months	This is the choke point. Some firms drag this through the contractual notice period.
3. New MAR submits change-of-establishment / change-of-holder filing via MeDC@St	New MAR	30–60 working days MDA processing	Class A faster; Class C/D can require CAB confirmation
4. Outgoing MAR confirms cessation of representation in MeDC@St	Outgoing MAR	up to 30 days	Mostly mechanical
5. Updated registration record issued by MDA	MDA	30–90 working days	Public via MDA registry
Total realistic timeline		60–150 working days (Class A/B), 90–210 working days (Class C/D)	Faster if outgoing MAR cooperates

The bottleneck is almost always step 2. MDA will not process a holder change without a transfer letter and the outgoing MAR's MeDC@St cessation confirmation. A MAR that wants to retain you can stall your departure by delaying these documents.

Contract Termination Clauses: How They Actually Compare

The termination clause buried in your MAR agreement is often more economically consequential than the headline annual fee. Common terms in the Malaysian and Singapore-based regional consultancy market:

Termination Term	Typical Industry Practice	Pure Global Published Term
Notice period required	6–12 months	None — termination effective with 50% payoff
Payoff of remaining contract value on early exit	100% of remaining contract	50% payoff of remaining contract
Transfer letter delivery commitment	Within "reasonable time" (undefined)	Standard contract term
MeDC@St handover commitment	Often unaddressed in contract	Within standard contract term
Separate "transfer fee" charged at exit	$1,500–$5,000 typical	None
Right to withhold registration certificate	Sometimes asserted	Explicitly waived in published terms

If you sign a typical industry MAR contract today that requires 12 months notice plus 100% payoff of remaining term, the effective cost of switching mid-contract on a $5,000/year deal is $5,000 (notice fees) + $10,000 (remaining 2-year payoff) + $3,000 (transfer fee) = $18,000 before you pay the new MAR a cent. That is more than 3 years of flat-fee under Pure Global's published rate for a single Class B device.

The Distributor-as-MAR Lock-In Trap

The most common trap for first-time Malaysia entrants: letting the in-country distributor double as the MAR. Up front it looks efficient — one relationship, no separate retainer, the distributor often offers MAR services "for free" as part of the commercial deal. The economic reality is harsher.

If your distributor holds the registration:

• Switching distributors usually requires a holder change, and sometimes a re-registration. Some MDA registrations are tied so closely to the licensee's Establishment Licence and GDPMD certificate that practical switching is closer to re-filing than a clean transfer — costing $5,000–$15,000 and taking 4–9 months for Class C/D, during which Letters of Authorization may not be issuable.
• The distributor has implicit veto power over your Malaysian commercial strategy. They can refuse to issue parallel LoAs to second importers, drag transfer letters, or trigger registration disruption during disputes.
• The "free MAR" is always priced into the distributor margin — industry practice is 8–18% commercial markup. For a $4M/year Malaysia business, that is $320,000–$720,000/year in implicit MAR cost paid to a counterparty whose interests can diverge from yours.
• GDPMD risk is not yours to manage but you bear it. If your distributor's GDPMD lapses, your registration and imports stop until the GDPMD is restored.

The right structure: an independent MAR holds the registration, and one or more distributors are authorized importers under that registration. Switching distributors becomes a commercial decision, not a regulatory one. You pay $2,000–$8,000/year for the MAR and recapture the 8–18% distributor margin.

Clean Switching: 7-Step Sequencing

1. Sign the new MAR first, with the contract conditional on successful transfer of named registrations.
2. Generate fresh Letters of Authorization in parallel; notarise (and apostille if required) before notifying the outgoing MAR.
3. Time the notice letter to land 30 days before the contract anniversary to minimize early-termination cost.
4. Cite specific contract clauses in your termination letter — transfer letter delivery and MeDC@St handover, in particular. Many MARs respond to legal pressure but not commercial requests.
5. File the change-of-holder via MeDC@St the day you receive the transfer letter — do not wait for batch processing.
6. Hold LoA coverage continuous — the incoming MAR should issue all LoAs starting from MDA approval date. Gaps mean stuck shipments at port.
7. Confirm UDI / MeDC@St / CAB-record credentials transfer — registration records, MeDC@St login ownership, and CAB-issued certificates all need explicit handover.

A well-executed switch costs $2,000–$5,000 in legal/operational time and 60–150 days of effort. A poorly executed switch can cost a year of market access. The termination clause is the upstream variable that determines which one you get — and is therefore the clause you should negotiate hardest before signing.

Named Provider RFP Comparison: Pure Global vs Typical Competitor Quotes

For this article we modeled the same scope — single Class B device, 3-year holder relationship, all standard inclusions — under three pricing structures: Pure Global (rates verified on its public pricing page), and two composite industry quotes (hourly and reg-plus-annual) built from typical RFP responses from Malaysian and Singapore-based regional MAR providers.

Composite columns use the midpoint of each range. Pure Global uses the published rate. Competitor firms are not named individually because they do not publish prices and we cannot publish their proposal data without consent.

Same Scope, Three Models, 3-Year Total

Scope baseline: 1 Class B medical device, MDA registration via Verification Route under MDA/GD/0070, foreign manufacturer, 3-year contract, average import volume (8 LoAs/year), 1–2 modifications per year (consistent with 2026 MDA churn).

Line Item	Pure Global (Flat Fee)	Composite Hourly Quote	Composite Reg+Annual Quote
Year 1 — initial filing & setup	$2,000 (annual fee)	$8,500 (45 hrs × $190 blended)	$5,500 ($2,000 setup + $3,500 filing)
Year 1 — translation (English/Bahasa Malaysia)	included	$1,000 (7 hrs T3)	$600–$1,500 per-page
Year 1 — 8 Letters of Authorization	included (importation authorization scope; volume cap not published — confirm)	$1,200 (8 hrs T3)	$400–$3,200 (per-letter fees)
Year 1 — CAB liaison and dossier resubmission	included	$1,400 (6 hrs T2)	$1,500–$4,000 separately quoted
Year 1 — 1 modification	included	$470 (2 hrs T2)	$500–$2,500
Year 1 total	$2,000	$12,570	$8,500–$16,700
Year 2 — annual maintenance	$2,000	$3,500 (20 hrs blended)	$2,500–$3,500 base
Year 2 — 2 modifications + 8 LoAs	included	$2,140	$1,400–$8,200
Year 3 — annual maintenance	$2,000	$3,500	$2,500–$3,500
Year 3 — 2 modifications + 8 LoAs	included	$2,140	$1,400–$8,200
3-Year Total	$6,000	$23,850	$16,300–$40,100

(Pure Global rates verified at pureglobal.com/services/pricing. Composite ranges drawn from typical Malaysian and Singapore-based regional MAR RFP responses observed by MedDeviceGuide; individual firm numbers vary.)

Key Takeaways from the Comparison

• Pure Global at the published rate is 3.97x cheaper than the composite hourly quote over 3 years, and 2.7x to 6.7x cheaper than the composite reg+annual quote.
• The cost gap widens in Years 2–3 if the device generates above-average modifications — given 2026 MDA churn (Act 737 amendments, aesthetic-device order, ePermit rollout, Singapore reliance conversions), the realistic case for most devices.
• The reg-plus-annual model has the widest bracket because providers vary enormously on whether modifications, LoAs, and CAB liaison are inside the fee or billed separately. Read every "included" claim line by line.
• The flat-fee model is insulated from invoice variance. The only variables you control are class tier and device count.

Why Composite Instead of Named Competitors

No other major MAR provider publishes prices. Naming Firm X with a specific number invites disputes we cannot resolve without violating NDAs on proposals we have seen, and every firm's quote varies by negotiation, scope, and volume — single-firm naming gives a misleadingly precise picture. The point of this analysis is the structural difference between pricing models, not which specific competitor is best.

If you want firm-specific pricing for a named competitor, the only way to get it is to issue your own RFP. The next section gives you a template designed to force apples-to-apples comparisons.

Recommended Reading

Clinical Equivalence Assessment Under EU MDR: Technical, Biological, and Clinical Equivalence

Clinical Evidence EU MDR / IVDR2026-04-24 · 12 min read

MAR RFP Template Copy and Paste

Most MAR RFPs come back in three different formats with three different scope inclusion lists, making side-by-side comparison impossible. Use the template below to force every responding firm into the same structure. Copy, paste, fill in the blanks, send.

---

Subject: Request for Proposal — Malaysia Authorized Representative (MAR) Services for [Manufacturer Name]

Dear [Provider],

[Manufacturer Name] is evaluating Malaysia Authorized Representative service providers for our medical device portfolio entering or maintaining presence in the Malaysian market under the Medical Device Act 2012 (Act 737). We are issuing this RFP to [N] firms and request a written proposal by [date].

Portfolio Scope

#	Device Name	MDA Class	Pathway (Verification / Full Conformity / Singapore Reliance)	Currently Registered?	Anticipated Modifications/Year
1	[Device A]	[A / B / C / D]	[Verification / Full / Singapore Reliance]	[Yes / No]	[N]
2	[Device B]

Contract Term: We anticipate a [3-year / 5-year] MAR relationship.

Required Pricing Format

Please provide pricing in the following table for each year of the contract term. Indicate explicitly whether each line item is included in the base fee or billed separately, and if separately, on what unit basis.

Service Item	Year 1 Cost	Year 2 Cost	Year 3 Cost	Inclusion (Y/N)	Per-Unit Rate if Separate
Initial registration filing per device (MeDC@St)
English / Bahasa Malaysia translation of submission docs
Letters of Authorization for importation — please state limit
Modifications — please state limit and definition
MDA additional-information request (AIR) response
CAB technical-review liaison and dossier handling
5-year registration renewal filing
Distributor authorization letters
Vigilance / adverse-event reporting (MDA Form 9 etc.)
FSCA filing
Aesthetic-device transition filings under P.U.(A) 2026 order
ePermit/DagangNet voluntary submissions
Out-of-scope hourly rate (T1 / T2 / T3)

Required Disclosures

1. Annual fee escalation clause — fixed, CPI-linked, or uncapped?
2. Notice period required for non-renewal at end of term.
3. Early termination payoff — what percentage of remaining contract value?
4. Transfer letter delivery commitment in days from termination notice.
5. MeDC@St account credential handover commitment in days from termination notice.
6. Any separate "transfer fee" charged at exit — yes/no, amount.
7. Government fees and CAB fees — confirm passed through at cost without markup.
8. Whether you hold the registration as an independent MAR or as a distributor-affiliate, and confirmation that you do not assert any right to withhold the registration certificate or MeDC@St account during a dispute.
9. Validity window of your own GDPMD certificate and MDA Establishment Licence (please attach copies).

Evaluation Criteria

We will evaluate proposals on (in order): (1) total 3-year cost at our forecast scope, (2) inclusion completeness — fewer separately-billed line items is better, (3) termination clause flexibility, (4) responsiveness during this RFP, (5) MDA filing track record (please attach 2–3 references with redacted MDA registration numbers).

Please respond by [date] to [contact email].

Best regards,

[Your Name]

[Your Title], [Manufacturer Name]

---

This template forces every MAR to price the same scope. The line items where firms diverge most — modifications, Letters of Authorization, MDA additional-information responses, CAB liaison, and termination clauses — are exactly the items the template makes them disclose explicitly. After three to five proposals come back in this format, the right answer for your portfolio is usually obvious within an hour of comparing.

Frequently Asked Questions

Is a Malaysia Authorized Representative the same as a distributor?

No. A MAR holds the MDA registration on behalf of the foreign manufacturer; a distributor imports and sells the device commercially. The same entity can play both roles, but combining them is generally a bad idea — if the commercial relationship sours, the distributor controls the registration and you cannot leave without re-registering or going through a slow holder transfer.

Can I be my own MAR?

Only if you have a Malaysian legal entity holding an MDA Establishment Licence and a valid GDPMD certificate. Most foreign manufacturers find that standing up and maintaining a Malaysian regulatory entity exceeds the cost of an independent MAR for the first 5–10 devices.

Does the MAR pay MDA government fees on my behalf?

Yes — the MAR submits payment via MeDC@St, but underlying MDA fees (MYR 250–750 application, MYR 750–3,000 registration) are reimbursed at cost. Reputable MARs do not mark up government fees. If a MAR refuses to pass through MDA fees at cost, walk.

What about the CAB fee — is that part of the MAR fee?

No. The CAB technical-review fee is a separate, third commercial relationship (typically MYR 8,000–25,000 for Class B, MYR 15,000–50,000+ for Class C/D). Pure Global's flat MAR fee covers CAB coordination and dossier liaison, but not the CAB's own fee. Always confirm the CAB fee is itemised separately and not marked up.

How long does a MAR transition take if I want to switch?

Typically 60–150 working days for Class A/B and 90–210 working days for Class C/D. Pure Global's standard 50% remaining-contract-value early-termination clause is among the more buyer-friendly in the industry — many MARs require full remaining contract payoff plus 6–12 months of notice.

What happens if MDA issues an additional-information request on my registration?

The reply window is typically 90 days. Under hourly billing, every hour spent on the response is billed. Under registration-plus-annual, responses are sometimes inside scope and sometimes billed separately at $500–$2,500. Under Pure Global's flat-fee model, routine AIR responses are likely inside the published "correspondence with authorities" scope, but substantive technical re-argument is not separately itemised on the price list — confirm in writing before signing. For borderline-classified Class C devices, this can be the single largest Year-1 line item outside the initial filing.

Can I use my Singapore HSA registration to shortcut the MAR work in Malaysia?

The Singapore reliance route (permanent from March 2026 under MDA/GD/0070 Second Edition) shortens the CAB and MDA review timelines, not the MAR commercial relationship. You still appoint a MAR, the MAR still files via MeDC@St, the MAR still issues Letters of Authorization.

Does the new aesthetic-device designation (June 2026) trigger new MAR work for existing registrations?

If your portfolio includes HIFU systems, medical lasers, or liposuction equipment — yes. The Designated Aesthetic Devices Order 2026 brings these under Act 737 from 1 June 2026. Under hourly or reg-plus-annual contracts, this is billable. Under a Pure Global flat-fee contract, the transition filing is likely inside the published "modifications" scope for already-contracted devices — but because the Order is new and the filing format is still being finalised by MDA, get the inclusion confirmed in writing before relying on it.

How does Malaysia MAR cost compare to other ASEAN markets?

Malaysia's MAR cost ($2,000–$8,000/year flat fee) sits in the same range as Singapore's Registrant ($2,000–$6,000/year) and Thailand's License Holder ($2,500–$7,000/year). Vietnam and Indonesia tend to be higher due to market complexity. See Medical Device Registration Cost by Country: 2026 Global Comparison for the full benchmark.

Bottom Line

Malaysia's three-fee architecture — MDA + CAB + MAR — is transparent at the first two layers. MDA fees are statutory; CAB fees converge around technical-review effort. The line item that wrecks budgets is the third one, specifically the cash-flow shape of when MAR fees hit. Hourly billing front-loads 60–75% of 3-year cost into Year 1, when there is no Malaysian revenue. Reg-plus-annual front-loads 50–55%. Flat all-inclusive billing flattens it to ~33% per year — the only pricing model that aligns with how MedTech revenue actually scales in a new market.

The numbers are 2026 benchmarks. The pricing-model questions are timeless. Ask them before you sign.

Related Guides

• Malaysia MDA Medical Device Registration Guide
• Singapore HSA Medical Device Registration Guide
• Thailand Medical Device Registration Guide
• Vietnam Medical Device Registration Guide
• Southeast Asia ASEAN Registration Guide
• Medical Device Registration Cost by Country: 2026 Global Comparison
• Medical Device Regulatory Consulting Hourly Rates by Region